Cytogenetics of 158 patients with regional or disseminated melanoma Subset analysis of near-diploid and simple karyotypes

Cancer Genetics and Cytogenetics

Volumn 83, Issue 2, 1995, Pages 93-104

  Thompson, Floyd H ^a   Emerson, Julia ^a   Olson, Sharon ^a   Weinstein, Ronald ^b   Anne Leavitt, S ^b   Leong, Stanley P L ^c   Emerson, Scott ^a   Trent, Jeffrey M ^d   Nelson, Mark A ^a   Salmon, Sydney E ^a   Taetle, Raymond ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARCINOGENESIS; CHROMOSOME 10; CHROMOSOME 11Q; CHROMOSOME 13P; CHROMOSOME 1P; CHROMOSOME 1Q; CHROMOSOME 6P; CHROMOSOME 6Q; CHROMOSOME 9P; CHROMOSOME ANALYSIS; CHROMOSOME BREAKAGE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME MAPPING; DIPLOIDY; FEMALE; HUMAN; KARYOTYPING; MALE; MELANOMA; MIDDLE AGE; SKIN NEOPLASMS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0029148164     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-4608(95)00057-V     Document Type: Article

References (61)

1. Epidemiology of malignant melanoma, worldwide incidence, and etiologic factors
2. Trisomy 6p in an ocular melanoma
3. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22
4. Cytogenetic findings in primary uveal melanoma
5. Chromosomal gains and losses in uveal melanomas detected by comparative genomic hybridization
6. Biology of disease. Molecular markers of melanocytic tumor progression
7. Cytogenetic analysis of uveal melanoma
8. Methods for chromosome banding of human and experimental tumors in vitro
9. Cytogenetic methodological approaches and findings in human solid tumors
10. An International System for Human Cytogenetic Nomenclature
11. Clonal chromosome abnormalities in 54 cases of ovarian carcinoma
12. Chromosomal segment representation profiles in human malignant melanoma, ovarian, breast, and colon carcinomas (abstract)
13. Chromosome alterations in human malignant melanoma
14. Statistical analysis of cytogenetic abnormalities in human cancer cells
15. Simple numeric abnormalities as primary karyotype changes in ovarian carcinoma
16. Comparative genomic hybridization — a rapid new method for detecting and mapping DNA amplification in tumors
17. Molecular cytogenetics in human cancer-diagnosis
18. Genetic alterations during colorectal-tumor development
19. Allelotype of colorectal carcinomas
20. Identification of a recurring translocation site involving chromosome 6 in human malignant melanoma
21. Cytogenetic methodological approaches and findings in human solid tumors
22. Amplification of cellular oncogenes in cancer cells
23. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia
24. The approaching era of the tumor suppressor genes
25. Expression of cellular oncogenes in human malignancies
26. The molecular genetics of cancer
27. High resolution chromosomes of the t(9;22) positive leukemias
28. Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11)
29. Localization of the chromosomal breakpoints of the t(12;16) in liposarcoma to subbands 12q13.3 and 16p11.2
30. Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma
31. Molecular detection of deletions involving band q14 of chromosome 13 in retinoblastoma
32. A deleted chromosome no. 13 in human retinoblastoma cells: relevance to tumorigenesis
33. Somatic deletion and duplication of genes on chromosome 11 in Wilms' tumours
34. Aniridia-Wilms' tumor association evidence for specific deletion of 11p13
35. Genetic characterization of 20q amplification in human breast cancer (abstract)
36. Human melanoma: Development and progression
37. Cytogenetics of melanocytic tumors
38. Further evidence for a locus for cutaneous malignant melanoma-dysplastic nevus (CMM/DN) on chromosome 1p, and evidence for genetic heterogeneity
39. Current status of the dysplastic melanocytic nevus
40. Possible involvement of the chromosome region 10q24-q26 in early stages of melanocytic neoplasia
41. Cytogenetic analysis of melanocytes from premalignant nevi and melanomas
42. Molecular definition of a chromosome 9p21 germ-line deletion in a woman with multiple melanomas and a plexiform neurofibroma: Implications for 9p tumor-suppressor gene(s)
43. Confirmation of chromosome 9p linkage in familial melanoma
44. Linkage of cutaneous malignant melanoma/dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity
45. Lentigo maligna-cytogenetic, ultrastructural, and phenotypic characterization of a primary-cell culture
46. A cell cycle regulator potentially involved in genesis of many tumor types
47. One gene-four syndromes
48. Chromosome 10 allelic loss in malignant melanoma
49. Loss of heterozygosity for 10q22-qter in malignant melanoma progression
50. Linkage mapping of melanoma (MLM) using 172 microsatellite markers
51. Molecular analysis of genomic abnormalities in human gliomas
52. Cytogenetic survey of 32 cancers of the prostate
53. Trisomy 7, trisomy 10, and loss of the Y chromosome in short-term cultures of normal kidney tissue
54. Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6
55. Benefit of elective lymph node dissection in subgroups of melanoma patients
56. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma
57. Analysis of the p16 gene (CDKn2) as a candidate for the chromosome 9p melanoma susceptibility locus
58. Germline p16 mutations in familial melanoma